Company profile for Transpire Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand...
We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand access to these complex inhaled medicines globally by developing and commercializing lower-cost generic alternatives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
8201 Peters Road Plantation, FL33324
Telephone
Telephone
+1.954.315.0224
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/15/3166934/0/en/Transpire-Bio-Granted-Orphan-Drug-Designation-by-the-U-S-FDA-For-Two-Rare-Diseases.html

GLOBENEWSWIRE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/09/23/3154541/0/en/Transpire-Bio-s-ANDA-for-Generic-Breo-Ellipta-Accepted-for-Filing-By-the-U-S-FDA.html

GLOBENEWSWIRE
23 Sep 2025

https://www.fiercebiotech.com/biotech/transpire-follows-boehringers-footsteps-licensing-pde4-inhibitor-lung-disease

FIERCE BIOTECH
04 Jun 2025

https://www.globenewswire.com/news-release/2025/05/06/3074874/0/en/Transpire-Bio-Announces-R-D-and-Manufacturing-Expansion.html

GLOBENEWSWIRE
06 May 2025

https://www.globenewswire.com/news-release/2025/01/13/3008412/0/en/Transpire-Bio-Announces-Progress-in-Clinical-Development-with-Initiation-of-a-New-Human-Subject-Study-for-Asthma-and-COPD-Inhaled-Drug-Program.html

GLOBENEWSWIRE
13 Jan 2025

https://www.globenewswire.com/news-release/2024/12/17/2998200/0/en/Transpire-Bio-Achieves-Important-Corporate-Milestone-with-Completion-of-First-Human-Subject-Study-in-the-Company-s-Asthma-and-Chronic-Obstructive-Pulmonary-Disease-Inhaled-Drug-Pro.html

GLOBENEWSWIRE
17 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty